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Abstract
Background: Normal-pressure hydrocephalus (NPH) is a neurodegenerative disorder that usually occurs late in adult life.
Clinically, the cardinal features include gait disturbances, urinary incontinence, and cognitive decline.
Methodology/Principal Findings: Herein we report the characterization of a novel mouse model of NPH (designated p23-
ST1), created by N-ethyl-N-nitrosourea (ENU)-induced mutagenesis. The ventricular size in the brain was measured by 3-
dimensional micro-magnetic resonance imaging (3D-MRI) and was found to be enlarged. Intracranial pressure was
measured and was found to fall within a normal range. A histological assessment and tracer flow study revealed that the
cerebral spinal fluid (CSF) pathway of p23-ST1 mice was normal without obstruction. Motor functions were assessed using a
rotarod apparatus and a CatWalk gait automatic analyzer. Mutant mice showed poor rotarod performance and gait
disturbances. Cognitive function was evaluated using auditory fear-conditioned responses with the mutant displaying both
short- and long-term memory deficits. With an increase in urination frequency and volume, the mutant showed features of
incontinence. Nissl substance staining and cell-type-specific markers were used to examine the brain pathology. These
studies revealed concurrent glial activation and neuronal loss in the periventricular regions of mutant animals. In particular,
chronically activated microglia were found in septal areas at a relatively young age, implying that microglial activation
might contribute to the pathogenesis of NPH. These defects were transmitted in an autosomal dominant mode with
reduced penetrance. Using a whole-genome scan employing 287 single-nucleotide polymorphic (SNP) markers and further
refinement using six additional SNP markers and four microsatellite markers, the causative mutation was mapped to a 5.3-
cM region on chromosome 4.
Conclusions/Significance: Our results collectively demonstrate that the p23-ST1 mouse is a novel mouse model of human
NPH. Clinical observations suggest that dysfunctions and alterations in the brains of patients with NPH might occur much
earlier than the appearance of clinical signs. p23-ST1 mice provide a unique opportunity to characterize molecular changes
and the pathogenic mechanism of NPH.
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Introduction
Normal-pressure hydrocephalus (NPH) is an adult-onset syndrome
involving non-obstructive enlargement of the cerebral ventricles [1].
Clinically, NPH is characterized by gait apraxia, urinary inconti-
nence, and dementia [2]. Gait disturbances are the most common
symptoms of NPH, and are usually the first to be observed. Postural
instability and falls are frequently characteristic of the disease [3].
Parkinsonism symptoms have also been reported in approximately
11% of NPH patients [4]. A late symptom is urinary incontinence,
which starts as an increase in urinary frequency and/or urgency, but
progresses to incontinence [5]. Cognitive impairment tends to be
predominantly subcortical in nature. Briefly, patients show various
defects including slow information processing, abnormalities in
memory and executive functions, reduced psychomotor activity,
visuospatial deficits, and mood changes without the presence of focal
cortical deficits [6,7,8]. Ventricular enlargement disproportionate to
the cerebral atrophy without macroscopic obstruction of cerebrospi-
nal fluid (CSF) flow is a featureof brain images. Usually, enlargement
of the frontal and temporal horns is relatively uniform and
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most common treatment for NPH patients, is usually effective in
partially ameliorating NPHsymptoms, but cannot completely restore
the damages caused by NPH [9]. To date, no mouse model with
these clinical features of NPH has been identified.
N-Ethyl-N-nitrosourea (ENU) mutagenesis has been widely
used to create a large number of germline point mutations, and is a
powerful tool for creating disease models [10]. Using a
combination of analyses that included magnetic resonance
imaging (MRI) and rotarod performance, we screened the
offspring of ENU-treated mice and identified a heritable mouse
mutant (designated p23-ST1) with clinical signs similar to NPH.
Further phenotypic and functional analyses suggested that p23-
ST1 is a novel model for NPH with a potential causative mutation
located within a 5.3-cM region on mouse chromosome.
Results
Brain MRI and Intracerebral Pressure of p23-ST1 Mice
Micro-MRI is a non-invasive imaging tool for monitoring brain
anatomy, function, and neurochemistry over time in the same
animal [11]. In a screening of 128 generation-3 (G3) mice, we
identified a mouse mutant (p23-ST1) with enlarged brain ventricles
that proved heritable (Supplementary Fig. S1). The size of the
ventricle was quantified using 3D-MRI (Fig. 1, Table 1). Mice with
brain ventricles larger than the mean ventricle size plus 3 standard
deviations (SDs) (Supplementary Table S1) were considered to be
affected mutants. Notably, the size (16.2662.16 mm
3,m e a n 6SD,
n=14) of the lateral ventricles (but not those of the cerebral
aqueduct or 4th ventricle) in mutant mice was much larger than
those of the wild-type mice (B6: 10.2062.82 mm
3,m e a n 6SD,
Figure 1. p23-ST1 mice exhibit enlarged ventricles starting from the age of 1 month. (A) Representative 3D brain MRI images from a
wildtype C57BL/6J mouse, a wildtype C3H/HeJ mouse, and a p23-ST1 mouse at the age of 3 months. The ventricle was further delineated into the
right lateral ventricle (magenta), left lateral ventricle (blue), 3
rd ventricle (yellow), the aqueduct (green), and 4
th ventricle (red). The ventricle size (mm
3)
of each brain was calculated and is shown in the left lower corner of each plate. Representative pictures of 2D MRI images (from the forebrain to the
cerebellum) of each mouse are shown. (B) The sizes of whole brains and brain masses of mutant and control mice were assessed at the age of 3
months. The size of the brain mass was calculated by subtracting the size of the ventricle from that of the whole brain. Data were compared by
Student’s t-test (*** p,0.001). No significant difference in the brain masses of mutant and control mice was observed, suggesting the absence of
gross brain atrophy in mutant mice. The enlarged ventricles in mutant mice apparently contributed to the slightly larger whole brains in mutant mice
when compared with those in control mice. (C) Ventricle sizes of mutant and control mice were assessed at the ages indicated on the x-axis using 3D-
MRI. The mean6SD at each point are plotted on the y-axis. Data were compared by Student’s t-test (*** p,0.001). Generally, ventricular size
increased with age in both mutant (red) and control (blue) individuals, but the sizes seen in the mutants statistically significantly differed from those
of the controls. (D) The intracranial pressures of mutant and control mice were measured at the age of 24 months. No significant difference in the CSF
pressure of mutant and control mice was found.
doi:10.1371/journal.pone.0007868.g001
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3, mean6SD, n=18; control:
5.7561.10 mm
3,m e a n 6SD, n=11) (Fig. 1A, Table 1, Supple-
mentary Table S1). This implies that the pathology is associated
more with the cerebrum rather than the cerebellum or brainstem.
As a consequence of ventricle enlargement, the overall size of
the brains of mutant mice (525.69624.89 mm
3, mean6SD,
n=14) was larger than that of control mice
(489.55618.21 mm
3, mean6SD, n=10) (Fig. 1B). This change
in ventricle size was detectable at an early age and persisted, with
gradual progression, throughout life (Fig. 1C). However, these
changes were not associated with a significant change in brain
mass between mutant (489.83626.97 mm
3, mean6SD, n=14)
and control mice (479.10618.06 mm
3, mean6SD, n=10)
precluding the possibility of gross atrophy. No significant change
in the volume of the corpus callosum between mutant
(8.0160.22 mm
3, mean6SEM, n=6) and control mice
(8.1060.45 mm
3, mean6SEM, n=6) was detected either.
The intracranial pressure (ICP) recordings in mutant mice were
similar to those of control mice [7.2560.34 mmHg (n=4) and
6.3360.23 mmHg (n=3), respectively; mean6SEM, p=0.21,
Student’s t-test] (Fig. 1D). This result suggests that despite an
increase in ventricle volume and brain size, p23-ST1 mutant mice
have NPH.
Ventricle Enlargement and the CSF Pathway of p23-ST1 Mice
To determine which part of the ventricle was enlarged in p23-
ST1 mutant mice, serial coronal sections along the axis of the
brain were microscopically examined. Consistent with 3D-MRI
analyses (Table 1), the sizes of the lateral and third ventricles of
mutant mice were larger than those of control mice, while no
difference in the size of the aqueduct or fourth ventricle between
these two groups was observed (Fig. 2A). Collectively, no apparent
obstruction in the ventricle of p23-ST1 mice was found. In
addition, conventional histological analyses revealed that the
choroid plexus, from which the CSF is secreted, of p23-ST1
mutant mice appeared normal when compared to that of control
mice (Fig. 2B).
To further verify whether an obstruction existed in the CSF
pathway of p23-ST1 mutant mice, a flow tracer (India ink) was
intraventricularly injected into the right lateral ventricle. An
obstruction in ventricles would have delayed the appearance of ink
in the ventricular system as well as in ink-tinged vessels. As shown
in Fig. 3, the injected ink diffused into the left lateral, third, and
fourth ventricles. Furthermore, ink-tinged vessels were evident in
the cerebral cortex (green arrows), cerebellum, and spinal cord
(black arrows) from both control and mutant mice. No signal was
found in the brain of control mice injected with saline. Taken
Table 1. 3D-MRI analysis of control and mutant mice at the age of 3 months.
Control (mm
3) Mean6SD; n=11 Mutant (mm
3)M e a n 6SD; n=14
4
th ventricle 2.2260.35 2.4060.45
Aqueduct 1.5060.41 1.4460.30
3
rd ventricle 3.0560.57 4.3060.75***
Lateral ventricle (left) 2.8760.68 7.7861.28***
Lateral ventricle (right) 2.8860.55 8.4861.07***
Total ventricle 12.5261.75 24.4062.45***
Volumes of the forth ventricle, aqueduct, third ventricle, left and right lateral ventricles, and total ventricle of mutant (n=14) and control (n=10) mice at the age of 3
months were measured by 3D-MRI. (Mean6SD; *** p,0.001, Student’s t-test).
doi:10.1371/journal.pone.0007868.t001
Figure 2. Histological assessment of the cerebrospinal fluid (CSF) pathway. (A) Serial coronal brain sections with H&E staining from 6-
month-old mutant (lower panel) and age-matched control mice (upper panel) revealed enlarged lateral and third ventricles in mutant mouse
compared to the control mice. The sizes of the cerebral aqueduct and fourth ventricle of the mutant mice were similar to those of control mice. Scale
bars=500 mm. (B) Histological analysis of the choroid plexus of mutant (lower panel) and control (upper panel) mice aged 24 months.
Microscopically, no hypertrophy or tissue swelling of the choroid plexus of mutant mice was found. Representative pictures of three independent
mice in each group are shown. Scale bars=100 mm.
doi:10.1371/journal.pone.0007868.g002
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p23-ST1 mice was due to a communicating hydrocephalus.
To exclude the possibility of tissue swelling in hydrocephalic
mice, the brain water content was measured. The percentages of
brain water were 79.3%60.8% and 79.6%61.2% for the control
and the p23-ST1 mutant mice, respectively (mean6SEM, n=4,
p=0.86, Student’s t- test).
Phenotypic Characterization of p23-ST1 Mice
Mutant mice (p23-ST1) were weighed every month starting
from the age of 1 month. Despite ventricular enlargement, the
general appearance and body weight (Supplementary Fig. S2) of
p23-ST1 mice did not overtly differ from those of their control
littermates throughout their lives. The heart rate of mutant mice
was similar to those of control mice (540.063.5 beats/min,
mean6SEM, n=3; and 550.5627.6 beats/min, mean6SEM,
n=3 respectively, p=0.72, Student’s t-test). The mean blood
pressure (BPm) of mutant mice were similar to those of control
mice (83.263.2 mmHg; mean6SEM; n=3 and 81.364.3
mmHg; mean6SEM, n=3 respectively, p=0.73, Student’s t-test).
No significant differences in serum biochemistry parameters
(including total cholesterol, triglyceride, glucose, magnesium,
calcium, creatinine, C-reactive protein, alanine aminotransferase,
creatinine kinase, amylase, and osmolarity) were found either
(Supplementary Table S2).
From the age of 18 months, p23-ST1 mice displayed poor
performance on the rotarod running test compared to control
mice (Fig. 4) suggesting a decline in motor coordination. To gain
insights into the nature of the motor coordination defect, mice
were examined using the ‘‘CatWalk’’ test. This allowed us to
examine the placement of their paws, the length of their stride, and
the path taken along the ‘‘walk’’. In this test, mutant mice
displayed a more-frequent repetitive stumble (i.e., multiple
attempts to place the same paw on or near the same spot) and a
shortening of step length compared to the normal controls (Fig. 5A,
B). By measuring the deviation in the path taken by mice from the
midline of the path and the position of the feet, we were able to
demonstrate that mutant mice walked with an unsteady, wobbly
swaying gait compared to controls (Fig. 5C, D). Further, the stride
length was smaller and base width between limb pairs was larger in
mutants than those observed in controls (Fig. 5E, F). This apraxic,
wide-based, small-step gait exhibited by the mutant mouse is
similar to the festinating gait of NPH patients [12].
A major feature of human NPH is urinary dysfunction or
incontinence. To assess whether p23-ST1 mice might also have
urinary problems in both the frequency and volume of urine
produced, the urination frequency and the amount of void urine
Figure 3. Assessment of the cerebrospinal fluid (CSF) pathway by an intraventricular injection of India ink. Mice (12 months old, n=3
in each group) were intraventricularly injected with India ink. Whole-brain (upper left panel and lower panel) and serial brain sections (upper right
panel) were analyzed 10 min post injection for ink distribution and diffusion in the brain of control (A) and mutant mice (B). Tissue sections from a
control mouse injected with saline are shown as a negative control (C). Diffuse ink was clearly observed in the lateral, third, and fourth ventricles of
both control (A) and mutant mice (B). Likewise, the darkly ink-stained vessels at the cerebrum (green arrows), cerebellum, and spinal cord (black
arrows) were also evident in both mutant and control mice. No dark-blue staining was found in the brain of the negative control (C). Yellow arrows
mark the injection sites. Representative pictures of three independent mice in each group are shown.
doi:10.1371/journal.pone.0007868.g003
Figure 4. Motor coordination assessment of p23-ST1 mice by
rotarod performance. Rotarod performances (at 24 rpm) of mutant
(red) and control (blue) mice were evaluated monthly. These data were
compared by Student’s t-test and were found to diverge at 18 months
of age (* p,0.05; ** p,0.01; *** p,0.001) with mutant individuals
performing less well than control individuals.
doi:10.1371/journal.pone.0007868.g004
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Methods). Urine samples produced by the mice were collected
onto chromatographic paper placed below the pivotal rod of the
rotarod operated at 4 rpm for 2 min. The size of each urine spot
was recorded in 12 independent tests on each mouse (Fig. 6A–C).
The urinary frequencies of mutant mice were significantly greater
than those of the control group (51.0%67.4% and 22.2%66.0%;
respectively; n=17 or 18, mean6SEM; p,0.05, Student’s t-test).
Likewise, the amount of urine (determined by measuring the size
of each spot, supplementary Fig. S3) voided by the mutants was
greater than that by the controls (129.1629.9 and 23.9610.2 ml,
respectively; n=17 or 18, mean6SEM, p,0.01, Student’s t-test).
Note that the overall urine output of an animal in each test under
a minimal stress is likely to be positively correlated with the
number of urination events under stress and might reflect poor
sphincter control and incontinence. Collectively, these data
suggest that p23-ST1 mice suffer from urinary dysfunction
(incontinence) consistent with that observed in NPH patients.
Cognitive decline and memory loss are other features associated
with the human disease. We therefore attempted to determine
whether mutant mice displayed a decline in mental faculties. To
assess this, we employed a fear-conditioning test involving an
auditory cue followed by an electric shock. After an initial training
period, the mice were either returned to the test chamber for 5
min with no auditory cue (contextual test) or placed in a similar
chamber with an auditory cue (memory test) 1 and 24 h after the
training session. The length of time the mice spent motionless
upon being placed in the chamber was recorded. These data are
presented in Fig. 7. Under all tested conditions, the time taken to
resume activity was shorter for mutant mice than control animals
(e.g., 35.3%64.3% and 52.6%67.4%; respectively; n=6,10,
mean6SEM; p,0.05, Student’s t-test; short-term auditory-cued
tests). Similar observations were also made for long-term (24 h)
tests. Taken together, these data suggest that mutant mice
displayed both short- and long-term memory deficits.
Previous studies on kaolin-induced hydrocephalus in rats identified
pathological changes that include neuronal cell damage and
proliferation of glial cells [13,14]. The mouse mutant was examined
for pathological changes in neurons and glial cells. Nissl staining was
used to establish both cell numbers and morphological changes.
Among the various areas of the brain examined at 24 months of age,
the septum from mutant mice displayed a marked increase in both
astrocytes and microglial cells but a reduction in neuronal cells
(Table 2; Fig. 8). To ascertain when these changes became manifest,
we examined brain samples taken at different ages (at 3,24 months).
This study established that glial cells increased and neuronal cells
decreased, within the dorsal lateral septal nucleus (LSD), at around 18
and 24 months of age, respectively (Fig. 8E). Immunohistochemical
analyses identified deformed NeuN-positive neurons (Fig. 8B),
increased numbers of activated astrocytes (glial fibrillary acidic
protein, GFAP; Fig. 8C, F), and chronically activated microglia
(ionized calcium-binding adaptor molecule 1, Iba1; Fig. 8D, G)
identified by their long, rod-shaped cell bodies with thicker processes
(Fig. 8D). Surprisingly, activated microglia cells were first detected in
Figure 5. Gait analysis of p23-ST1 mice. The gait status of aged mice (20,24 months old) was assessed by the CatWalk automatic gait analysis
system. Real-time gait images of mutant and control mice are shown in panels A, C, and E. Footprint colors were assigned by the program (green,
right; red, left; light, forelimbs; dark, hindlimbs). (A) Stumbling gait (i.e., gait apraxia, white arrows) of mutant mice (lower trace) but not control
individuals (upper trace). Note that the forepaws were conspicuously affected. (B) Percentages of mis-placed feet in both mutant and control mice
are presented graphically. The difference between the two groups was significant at p,0.01. (C) The unsteady, wobbly gait of mutant mouse
compared with a control animal that moved in a straight line. The distance between the left (white line) and right (yellow line) path along with the
midline was determined. (D) Graphical presentation of these data. The shift from the midline was more significant in mutant than control mice
(p,0.05). To evaluate the motor performance and gait balance, the distance of the stride lengths as well as the distance between the bilateral paws
were measured (E and F). Mutant mice showed a reduction in stride length and a wider base between the hind paws (p,0.05) (F). Data are
presented as the mean6SEM in each group.
doi:10.1371/journal.pone.0007868.g005
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(Fig. 8G). All these changes are indicators of chronic inflammation;
inflammatory responses thus occurred in p23-ST1 mice, as are found
in NPH patients [15].
Genetic Characterization of Affected p23-ST1 Mice
To map the causative mutation, p23-ST1 mice (B6 genetic
background) were outcrossed with C3H mice, because of their
genealogical distance and similarities in ventricle size (Supple-
mentary Table S1). To determine the inheritance pattern, four
mutant mice (either homozygous or heterozygous for the
mutation) were out-crossed to wild-type C3H mice. A significant
portion (35 of 45, 77.8%) of the offspring exhibited enlarged
ventricles (ventricle size $ mean +3 SDs). This percentage is much
higher than what would be expected if the mutation arose de novo,
or was inherited as either a recessive or sex-linked gene. Thus, the
mode of inheritance is consistent with an autosomal dominant trait
displaying variable penetrance.
To map the disease gene, B6/C3H F1 mutant mice were inter-
crossed to produce F2 offspring. Mutant F2 offspring were out-
crossed to C3H, and the mutant offspring from this cross were
backcrossed to C3H. Mutant backcrossed offspring were then
inter-crossed to produce mutant F2 offspring that were again
backcrossed to C3H. This breeding program was repeated three
more times, and the offspring were used in the mapping studies.
Given this breeding strategy and assuming an autosomal dominant
mode of inheritance, the percentage of B6 alleles at linked loci in
mutant mice should have been greater than those present in
control mice. For the initial mapping study, a subset 18 mutant
mice (with ventricles $ mean +8 SDs), and 11 control mice (with
ventricles # mean 22 SDs) were subjected to a genome-wide SNP
screening comprising 287 markers. From this analysis, the greatest
frequency of B6 alleles was observed on chromosomes 4, 7, 14,
and 19 in mutant mice (Supplementary Fig. S4). The involvement
of chromosome 7 was excluded because the B6 genotype
frequency of control mice was also as high as mutant mice at
90% (Supplementary Fig. S4). Further allelic frequency analyses
with an expanded population (n=64) showed that the association
was more prominent for chromosome 4 than chromosome 14 or
19 (Supplementary Fig. S5). A higher difference in the percentage
of homozygosity (B6/B6) between the moderate phenotype
(ventricle size $ mean +5 SDs) and the extreme phenotype ($
mean +8 SDs) was also noted for chromosome 4 (Fig. 9A). For
dominant mutations, gene dosage is a common factor affecting the
phenotype, in that homozygotes, if viable, are more likely to
exhibit extreme characteristics. To test this hypothesis, we
compared the phenotype with the genotype and observed that
affected individuals with ventricle sizes of greater than the mean
+5 SDs were more often heterozygous for alleles in the disease
gene region, whereas those with ventricles larger than the mean +8
SDs were more often homozygous (homozygosity of 41% and 56%
respectively, Fig. 9A). In contrast, control mice only exhibited 13%
homozygosity for B6 alleles (Fig. 9A). This phenomenon was not
observed for other chromosomes implicated in the initial linkage
Figure 6. Urination dysfunction of p23-ST1 mice. (A) Urination of
aged mice (20,24 months old) on filter paper under mild stress (4 rpm
on the rotarod) was determined. The amount of urine released was
assessed by the urine-soaked areas on filter paper. Both urine frequency
(B) and volume (C) were quantified. Data are presented as the
mean6SEM in each group. Statistical analyses were conducted using
Student’s t-test (* p,0.05, ** p,0.01, compared to control mice).
doi:10.1371/journal.pone.0007868.g006
Figure 7. Memory impairment of p23-ST1 mice. Memory function
of aged mice (18,24 months old) was assessed by auditory fear
conditioning. Both short- and long-term memory were assessed by
measuring the length of time an animal froze following an auditory cue
1 (short-term) and 24 h (long-term) after initial training. Data are
presented as the mean6SEM for each group. Statistical analyses were
conducted using Student’s t-test (* p,0.05, ** p,0.01, compared to
control mice).
doi:10.1371/journal.pone.0007868.g007
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micro-satellite markers in the region defined by rs13477916 and
rs3091114 further refined the interval to suggest that the disease
locus lay in a 5.3-cM region between rs13477959 and rs3091114
(Supplementary Fig. S6, Table S2). With an LOD score of 14
(Fig. 9B), the association of the disease gene with this region of
chromosome 4 was highly significant.
Given the complexity of the linkage analysis, reverse mapping
was used as a reciprocal approach to confirm the linkage. We
compared ventricle sizes among the three groups of mice:
homozygous for B6/B6, heterozygous for B6/C3H, and homo-
zygous for C3H/C3H in the candidate region
(rs13477959,rs3091114). As shown in Fig. 9C, ventricle sizes of
mice harboring at least one B6 allele were significantly larger than
Figure 8. Alterations in the numbers of neurons, astrocytes, and microglia in the dorsal lateral septal nu (LSD) of p23-ST1 mice.
Brain sections containing the LSD from mutant and control mice (n=3,6) were stained with Nissl stain (A, E), or the corresponding antibody against
a neuronal marker (NeuN, B), an astrocyte marker (GFAP, C), or a microglia marker (Iba1, D). The density (A) and morphology (B) of LSD neurons were
altered in mutant mice (A, arrows). Activation of astrocytes with thicker processes was also evident in mutant animals (C, F). The number of
chronically activated microglia, characterized by their elongated and bipolar morphology with Iba1-positive immunoreactivity, was markedly
increased in mutant mice (D; arrowheads, G). Representative pictures of the LSD of aged p23-ST1 mice are presented (A, B, C, D). A specific
comparison between mutant and control mice was conducted using Student’s t-test (* p,0.05, ** p,0.01, *** p,0.001). Data are presented as the
mean6SEM.
doi:10.1371/journal.pone.0007868.g008
Table 2. Neuronal and glial cell numbers in the brain areas surrounding the ventricle of mutant and control mice.
LSD SHi LSV MS Striatum Cortex
Neuron Glia Neuron Glia Neuron Glia Neuron Glia Neuron Glia Neuron Glia
(N610
4/mm
3)( N 610
4/mm
3)( N 610
4/mm
3)( N 610
4/mm
3)( N 610
4/mm
3)( N 610
4/mm
3)
Control(n=6) 6.5760.35 5.8962.11 7.4560.83 5.7760.47 14.3660.48 6.2960.34 7.3660.29 9.6860.58 12.7760.62 7.1660.44 10.4960.26 6.7160.28
Mutant (n=5) 4.6160.36** 9.1260.63*** 5.4360.59 6.4260.82 12.3161.19 8.2160.71* 5.6360.52* 9.8760.68 9.5260.52** 10.7560.21*** 9.0760.51* 7.6260.15*
To visualize neurons and glial cells, brain sections from mutant and control mice (24 months old, n=5 or 6) were stained with Nissl stain. Examples of the results
obtained are shown in Fig. 8. Student’s t-test was used to compare the data (mean number of cells6SEM) from mutant and control individuals (* p,0.05; ** p,0.01;
*** p,0.001). LSD, lateral septal nucleus, dorsal; SHi, septohippocampal nucleus; LSV, lateral septal nucleus, ventral; and MS, medial septal nucleus.
doi:10.1371/journal.pone.0007868.t002
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151 (94%) mutant mice shown in Fig. 9C had at least one B6 allele
in the candidate region, further supporting our hypothesis that the
responsible mutant gene is linked to this 5.3-cM region on mouse
chromosome 4. The other 6% of mutant mice which had enlarged
ventricles but were homozygous for the C3H loci might have
resulted from spontaneous mutations [16] or natural variations in
ventricle size.
Discussion
In the present study, we identified an ENU-induced mutant
mouse with hereditary ventriculomegaly. The cardinal clinical
features were gait apraxia and ataxia, urinary incontinence, and
cognitive decline (Figs. 4–7). Although p23-ST1 mice exhibit
enlarged ventricles, ICP monitoring showed that they have normal
ICP. The phenotype was transmitted in an autosomal dominant
type with partial penetrance. Our linkage data suggest that the
disease locus maps to a 5.3-cM region of mouse chromosome 4
between rs13477959 and rs3091114. Although the mode of
transmission might not follow a simple dominant Mendelian trait,
using a model-free association study, a 2 by 2 comparison of the
data still provided evidence of genetic linkage to the 5.3-cM region
on chromosome 4 (x
2=16.14, p,0.001, Supplementary Table
S3). The disease odds ratio and relative risk ratio were 2.96 and
1.52, respectively, further strengthening its association with
hydrocephalus.
A few autosomal recessive mutations leading to hydrocephalus
were previously reported in mice [17,18]. Furthermore, mutations
in two different genes (Foxc1 and Lmx1a) were found to be
responsible for two hydrocephalus mouse models, congenital
hydrocephalus (ch) and dreher (dr) mice, respectively [19,20].
Nonetheless, in addition to congenital hydrocephalus, defects in
other organs (such as the cardiovascular system, bones, and
kidneys) were also found in these congenital mutant or genetically
modified mouse models [21,22,23], which rather differs from p23-
ST1 mice or NPH patients. In addition, none of the genetic loci
for these models are located on chromosome 4. The spontaneously
mutated hydrocephalus-3 (hy3) mouse is another interesting
hydrocephalus mouse model which exhibits hydrocephalus, nasal
discharge, and runting [24,25]. The causative mutation is
currently unknown, but was mapped to mouse chromosome 8
[26]. In addition to mouse models, a rat hydrocephalus model (the
H-Tx rat) with an onset during late gestation was reported [27].
Interestingly, the inheritance mode of the H-Tx rat is rather
complex. Quantitative trait locus mapping revealed that the
hydrocephalus trait loci of the H-Tx rat were located on four
different chromosomes (9, 10, 11, and 17), which differ from the
linked mutant region (orthologous to the rat chromosome 5q36) in
p23-ST1 mice. Taken together, p23-ST1 is a new rodent model of
hydrocephalus.
Pathological characterization of p23-ST1 mice showed marked
astroglial and microglial reaction as well as a significant loss of
neurons in septal areas (Fig. 8). Several neuropathological findings
associated with human and experimental hydrocephalus revealed
focal destruction of the ependyma, changes in the cerebral
vasculature, and ensuing damage to axons and oligodendrocytes
around the ventricles [13,28]. Reactive changes in glial popula-
tions were also reported in subependymal zones [13,28]. These
pathological alterations might result from a combination of
mechanical distortion and impaired cerebral blood flow. Interest-
ingly, the gliosis associated with degenerative hydrocephalus can
be ameliorated by shunt treatment [29]. In the hydrocephalic
brain (post-hemorrhagic and congenital types), an astroglial
Figure 9. A region on chromosome 4 carries the susceptibility
gene for hydrocephalus. p23-ST1 mice with a B6 genetic
background were outcrossed to C3H/HeJ mice and genotyped for the
presence of B6 alleles across the genome (Supplementary Fig. S4).
Chromosomes with the greatest proportion of associated B6 homozy-
gosity were identified (A). By far the greatest proportion of B6
homozygosity (60%) in individuals with extreme phenotypes ($ mean
+8 SDs, n=56; purple), was associated with a region on chromosome 4
between rs13477916 and rs3091114. Control individuals (i.e., those with
a ventricular volume of ,2 SDs from the mean) had only around 12%
B6 homozygosity for the same region (blue), whereas the moderate
phenotype (ventricle size $ mean +5 SDs) had about 40% (gray). The
other two likely chromosomal regions on 14 and 19, identified in the
initial genome scan (Supplementary Fig. S4), yielded much-smaller
differentials among the three groups. (B) LOD scores at the linked locus
on chromosome 4 from mutant mice. Under the assumption of
autosomal dominant transmission and using an intercrossing scheme,
LOD scores at the linked locus on chromosome 4 were calculated using
the MapManager QTX software in 31 mutant mice with extremely large
ventricles ($ mean +8 SDs). (C) Ventricular volumes in mice that were
C3H or B6 homozygotes or B6/C3H heterozygotes in the region defined
by rs13477959 and rs3091114 on chromosome 4. The mean ventricle
sizes of the homozygous B6/B6 and heterozygous B6/C3H mice were
significantly larger compared to mice with the homozygous C3H/C3H
genotype (** p,0.01, *** p,0.001, Student’s t-test).
doi:10.1371/journal.pone.0007868.g009
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periventricular white matter which is similar to what we identified
in the mutant mice [30]. In addition to an increase in astrocytes,
the number of chronic reactive microglia cells was also markedly
elevated in the periventricular region of affected mice (Fig. 8D, G).
Similar findings were reported in congenital hydrocephalus of
both humans and rats [31,32]. Specifically, Ulfig et al. [32]
reported numerous macrophages located focally along the
ependymal lining of the lateral ventricle, and intense microglial
activity within the periventricular regions of the parenchyma in
fetal hydrocephalus brains. Increasing evidence indicates that the
appearance of chronically activated microglia reflects a sustained
local inflammatory response. Since chronically activated microglia
were found in the septal area of p23-ST1 mice at a relatively
young age (3 months old) and throughout their lives, this
phenomenon seems to play a critical role in NPH. Our finding
that microglial activation occurred in brains of p23-ST1 mice is
consistent with an earlier study describing how the levels of an
inflammatory marker (tumor necrosis factor-a) in the CSF of NPH
patients are higher than those in the normal population [15]. Early
pathological changes preceding a long latency period prior to the
emergence of clinical symptoms is not an uncommon feature in
neurological diseases. Huntington’s disease provides an example of
early pathological changes affecting the caudate nuclei which
predate the occurrence of clinical signs [33]. Therefore, we
anticipate that further investigations on the inflammatory
responses in the periventricular region of p23-ST1 mice will
greatly increase our understanding of the NPH pathogenesis.
To date, patients with NPH can only be diagnosed after major
clinical signs have appeared. Due to a lack of appropriate animal
models, the timing of onset of ventricle enlargement and
neurochemical abnormalities in NPH has never been deter-
mined. In 1964, McHugh described the autopsies of several
patients with congenital hydrocephalus who had become
symptomatic at an older age [34]. Graff-Radford and Godersky
later found that three of 30 NPH patients had a head size at or
above the 98
th percentile [35], thus concluding that NPH
occurred as a result of decompensation of arrested congenital
hydrocephalus. In a more-recent report, Krefft et al. [36] showed
that the head sizes of both male and female patients with NPH
are statistically larger than those of the normal controls.
Collectively, a significant proportion of patients with NPH may
have congenital hydrocephalus that becomes symptomatic later
in life which is reminiscent of McHugh’s conclusion. It is very
likely that dysfunctions and alterations in the brains of patients
with NPH might occur long before the appearance of clinical
signs. p23-ST1 mice therefore provide an unique opportunity for
characterizing the molecular changes and the pathogenic
mechanism of NPH.
Familial cases of congenital hydrocephalus have occasionally
been reported in humans and may result from defects in single
genes or multifactorial determinants [37]. The most common form
of hydrocephalus is X-linked hydrocephalus which is usually
associated with stenosis of the aqueduct of Sylvius, and the gene
responsible for this disease (L1CAM) was identified [38].
Nevertheless, other forms of congenital hydrocephalus are mostly
multifactorial with a recurrence risk of about 4% [39]. Familial
adult-onset cases are unusual, and the genetic basis remains
obscure. To date, only two cases of familial hydrocephalus have
been reported with an autosomal dominant mode of inheritance.
Varadi et al. [39] described two siblings with apparent
hydrocephalus that exhibited late-onset gait disturbance, urinary
frequency, and cognitive impairment. Both patients markedly
improved after the shunt procedure. Chalmers et al. [40] recently
reported a family in which the presumed mode of inheritance was
autosomal dominant with variable penetrance. These observations
demonstrate that there are human forms of NPH that exhibit an
autosomal dominant mode of inheritance with variable pene-
trance. Our mouse model of this disease syndrome recapitulates
the clinical signs in these individuals and is likely to prove
extremely useful in defining the disease pathology of this human
syndrome. Our genetic study should eventually lead to the
identification of the disease gene which could be used to screen
human patients with NPH.
Materials and Methods
Ethics Statement
All animal experiments performed were reviewed and approved
by the Institutional Animal Care and Use Committee of Academia
Sinica.
Generation of ENU-Mutated Mice
Offspring from ENU-mutated C57BL/6J (B6) mice were
generated as previously detailed [41]. In brief, B6 male mice
were injected intraperitoneally with three consecutive weekly
injections of ENU (100 mg/kg). Following their recovery to
fertility, they were crossed to B6 females to produce generation
one (G1) males. The G1 males were further crossed to B6 females
to produce G2 females. These G2 females were backcrossed to
their sires. The offspring (G3) from these backcrosses were
subjected to a phenotype screening. All of these mice were
generated in the Mouse Mutagenesis Core Program Facility and
were maintained in the animal core facility of the Institute of
Biomedical Sciences, Academia Sinica, Taipei, Taiwan. Food and
water were available ad libitum. C3H/HeJ (C3H) mice were
purchased from the National Laboratory Animal Center, Taipei,
Taiwan.
Intracerebral Pressure (ICP) Monitoring
Mice (24 months old) were anesthetized by an intraperitoneal
injection of sodium pentobarbital (80 mg/kg). Sodium pentobar-
bital was chosen because it is an anesthetic commonly used in
animal studies for measuring intracranial pressure [42,43]. ICP
was measured by drilling a small hole (3 mm in diameter) through
the skull and inserting a CODMAN MICROSENSOR ICP
transducer connected to an ICP EXPRESS monitor (Johnson and
Johnson Medical, Raynham, MA, USA) into the frontal lobe of
the brain. After a recording period of 5 min, the average ICP
reading was recorded and compared with previously established
control data [44].
Analysis of the CSF Pathway
Mice (12 months old, n=3 in each group) were anesthetized by
an intramuscular injection of a mixture of ketamine (100 mg/kg),
xylazine (20 mg/kg), and atropine (2 mg/kg). A small burr hole
was drilled into the right parietal bone, 1 mm lateral to the
bregma. The head was fixed to a stereotaxic apparatus, and the
needle of a microsyringe was inserted into the right lateral
ventricle 3 mm from the brain surface through the burr hole.
Indian ink (4 ml, 20,50-nm particle size; Pelikan AG, Hanover,
Germany) was slowly injected into the right lateral ventricle at a
speed of 60 ml/h. Ten minutes after the injection, the mice were
decapitated. The brain was quickly removed, and the dyed
meningeal vessels were photographed. The brain was then cut into
pieces along the sagittal plane to trace the ink flow within the
ventricles.
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Brains were removed from the animals (12 months old, n=4in
each group) as described above, weighed for the wet weight, and
then dried in an oven at 95uC for 48 h to obtain the dry weight.
The water content was calculated by the following equation
described elsewhere [45].
Water content (%) = [(wet weight-dry weight)/wet weight]
6100%
Blood Pressure
Mice (12 months old, n=3 in each group) were anesthetized by
inhalation of 1% isoflurane. The mean blood pressure and heart
rate of anesthetized mice were measured using a blood pressure
monitor (Model MK-2000; Muromachi Kikai, Tokyo, Japan).
Serum Biochemical Parameters
Blood samples collected from mice (12 months old, n=3 in each
group) using submandibular sticks were used to produce serum,
and analyzed by the Taiwan Mouse Clinic (Taipei, Taiwan).
Levels of total cholesterol, triglyceride, glucose, magnesium,
calcium, creatinine, C-reactive protein, alanine aminotransferase,
creatinine kinase, and amylase were determined by the Dri-Chem
clinical chemistry analyzing system (FDC 3500; Fuji, Tokyo,
Japan) following the manufacturer’s protocol. The osmolarity of
the serum was determined using the micro-osmometer (Advanced
model 3300; Advanced instrument, Norwood, MA, USA).
Motor Function
Motor coordination was assessed by performance on a rotarod
apparatus(UGOBASILE,VialeG.Borghi,Comerio,Italy).Fromthe
age of 5 months, mice were first trained on the rotarod device before
testing.Thistraininginvolvedslowlyincreasingthespeedoftherotarod
d e v i c ef r o m4t o4 0r p mo v e rat i m ec o u r s eo f1 0m i n .T h e s et r a i n i n g
sessions were repeated three times prior to testing. As a result of this
training, it was determined that a speed of 24 rpm for 2 min was
sufficient to distinguish between mice with enlarged ventricles
compared tothosewithnormal-sizedventricles[46].
Following the initial training and testing, mice were retested
three times in the first week of each month until they reached the
age of 24 months when the study was terminated. The time
interval taken before the mouse fell from the rotarod was
automatically measured within the time interval of 2 min. The
maximum retention interval recorded by each mouse was used for
comparisons between individuals.
Gait
The gait of control (n=5) and mutant (n=10) mice aged 20,24
months was analyzed using a CatWalk gait automatic analyzer
(Noldus Information Technology, Leesburg, VA, USA). The
position, timing, and dimensions of each footfall were recorded by
a video camera positioned underneath a glass plate. The stride
distance and position of each paw from the mid-line was recorded
and analyzed using ImageJ software (Research Services Branch of
the National Institute of Mental Health, Bethesda, MD, USA)
[47].
Magnetic Resonance Imaging (MRI)
The ventricle size of control and mutant mice (aged 1, 3, and 24
months) was assessed using micro-MRI. Mice were anesthetized
by inhalation of 5% isoflurane at an oxygenation rate of 1 L/min,
and maintained in the magnet with 2%,3% isoflurane at 1 L/
min oxygenation [48]. Three dimensional (3D) ventricle and
whole-brain images were evaluated using a Bruker, Pharmascan
(7-Tesla) scanner (Bruker Biospin, Ettlingen, Germany) as detailed
earlier [46]. Sagittal T2-weight rapid acquisition relaxation
enhancement (RARE) images (TR=2000 ms, TEeff=88.3 ms,
FOV=3 cm, matrix=2566128) were acquired and used for the
location and length determinations of the brain. T2-weighted 3-D
RARE scans were acquired axially (TR=4000 ms,
TEeff=80 ms, Fov=2 cm, voxel size=2.86610.6 cm, ma-
trix=2566128664). The regions of interest within the ventricle
were manually delineated into the right lateral ventricle, the left
lateral ventricle, the 3
rd ventricle, the aqueduct, and the 4
th
ventricle. The voxels assigned to these individual parts of the
ventricles were summed and multiplied by the voxel size to obtain
their respective volumes, and the total ventricular volume
represents the sum of these separate measurements. All images
were processed using a manual tracing tool and edge editing
function provided by ANALYZE (Biomedical Imaging Resource,
Mayo Foundation, Rochester, MN, USA).
Urination Test
Control and mutant mice aged 20,24 months were subjected
to mild stress on rotarod at a fixed speed of 4 rpm for 2 min. The
amount of voided urine was collected on a piece of Whatman
chromatography paper (3 mm thick, 52.5 cm
2) placed on top of
the sensor plate of the rotarod. Each animal was tested three times
between 14:00 and 16:00 on three consecutive days at monthly
intervals. Urine frequency was calculated by dividing the number
of tests in which urination occurred by the total number of tests.
The urine-soaked area of each filter paper was scanned, quantified
by ImageJ, and transformed into a volume of urine based on a
carefully calibrated standard curve (Supplementary Fig. S3).
Cognitive Function
Mice (20,24 months old) were subjected to fear conditioning
trials associated with an auditory cue followed by an electric shock
(Med Associates, Saint Albans, VT, USA). In these trials, a mouse
was allowed to explore the conditioning chamber for 2 min. After
this period, they were subjected to a 30-s broadcast of white noise
(90 dB) followed by an electric shock to the feet for 2 s. For the
contextual test, mice were returned to the same training chamber
for 5 min without an electric shock. For the cued test, mice were
placed in a similar chamber (but lacking the steel rods used to
deliver the electric shock) for 3 min, after which they were then
exposed to the 90-dB white noise for 3 min. Their response to
these test conditions was observed, and the duration of time spent
motionless was recorded. Trials were conducted 1 and 24 h after
the initial training session to assess short- and long-term memory,
respectively [49].
Brain Tissue Preparation, Immunohistochemical Analyses,
and Quantitation
Three to six mice at 3, 6, 18, and 24 months of age from each
group were anesthetized by an intraperitoneal injection of sodium
pentobarbital (80 mg/kg) prior to intracardial perfusion with 4%
paraformaldehyde in 0.1 M phosphate buffer (PB, pH 7.4).
Following perfusion, the brains were removed and fixed for a
further 24 h in the same solution. After this period, brains were
placed in a 30% sucrose solution made up in 0.1 M PB. The tissue
was frozen, and 20-mm cryostat sections were taken (HM430,
Microm, Germany). Those containing the septum, striatum, and
cortex (interaural 4.66 mm/bregma 0.86 mm to interaural
4.18 mm/bregma 0.38 mm) were used for Nissl staining and
immunohistochemistry employing the avidin-biotin peroxidase
complex (ABC) method [46]. In Nissl-stained brain sections,
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dark with condensed nuclei. Astrocytes and microglia were
identified by immunohistochemistry using a polyclonal antibody
to GFAP (1:2000, Sigma, St Louis, MO, USA) or Iba1 (1:1000,
Wako Pure Chemical Industries, Osaka, Japan), respectively.
Because the Iba1 antibody recognizes all stages of microglia, these
cells were classified according to previously defined morphological
features [50,51]: (1) ramified (or resting) microglia have a round
cell body with thin cytoplasm and fine processes producing a long/
short axis ratio of 1:1; (2) rod-like (or activated) microglia are
hypertrophic with thick cytoplasm and thick short processes
producing a long/short axis ratio of ,3:1; and (3) elongated/
bipolar (or chronically activated) microglia have an elongated cell
body with bipolar thick processes producing a long/short axis ratio
of $3:1 (see Supplementary Table S4). Cells were counter-stained
with either an anti-NeuN antibody (1:500; Chemicon, Temecula,
CA, USA) as previously described [52] or Hoechst 33342. Optical
(Carl Zeiss, Oberkochen, Germany), and laser confocal (LSM510,
Carl Zeiss) microscopy was used to quantify at least 6000 cells
from each brain section.
Genetic Analysis
ENU-treated mice originating from a B6 genetic background,
were outcrossed to C3H mice for genotyping. DNA from these
outbred offspring was extracted using a Genomic DNA Purifica-
tion Kit (Promega, Madison, WI, USA). Single nucleotide
polymorphism (SNP) genotyping was carried out by the National
Genotyping Center at Academia Sinica using the SEQUENOM
MassARRAYH System (Sequenom, San Diego, CA, USA).
Marker information used for gene mapping can be found at
Ensembl (http://www.ensembl.org/Mus_musculus/index.html)
and is listed in Supplementary Table S5. The recombination
frequency was calculated and analyzed using MapManager
QTXb06 (Manly et al., 2001). A x
2 square test and the relative
risk ratio were used to evaluate the susceptibility of the affected
allele.
Supporting Information
Figure S1 2D-MRI analyses of a wildtype C57BL/6J mouse (A)
and a p23-ST1 mouse (B) at 3 months old. The representative
p23-ST1 mouse showed enlargement of the lateral ventricles.
Found at: doi:10.1371/journal.pone.0007868.s001 (0.75 MB
TIF)
Figure S2 p23-ST1 mice which exhibited normal bodyweight
(A) and locomotor activity (B).
Found at: doi:10.1371/journal.pone.0007868.s002 (0.44 MB
TIF)
Figure S3 Standard curve for the measurement of urinary
volume on 3-mm Whatman chromatography paper.
Found at: doi:10.1371/journal.pone.0007868.s003 (0.43 MB TIF)
Figure S4 Linkage analysis for hydrocephalus by whole-genome
screening. The B6 genotype frequency, defined as the percentage
of individual animals that contained at least one copy of the B6
allele, of mutant and control mice was analyzed by whole-genome
screening using 287 SNP markers.
Found at: doi:10.1371/journal.pone.0007868.s004 (0.56 MB TIF)
Figure S5 Genetic map of p23-ST1 mice at the linked locus.
Percentages of the B6 allelic frequency at chromosomes 4, 14, and
19 were analyzed. On chromosome 4, the percentages of the B6
allelic frequency in mutant mice ($ mean +8 SDs, n=56; open
circles) reached 70%; in contrast, in control mice (# mean 22
SDs, n=8; filled circles), it was only 35% in a linked region
(flanked by rs13477838 and rs13477993) on chromosome 4.
Found at: doi:10.1371/journal.pone.0007868.s005 (0.49 MB
TIF)
Figure S6 Fine mapping of the genetic map at the linked locus
of chromosome 4. Percentages of B6 allele frequency (A) and B6
homozygosity (B) in the linked locus (rs13477838,rs13477993)
on chromosome 4 in mutant and control mice were analyzed
using additional SNP (rs13477964, rs6224690, rs27565906,
rs134779969, rs6228499, and rs6334695) and STRP (D4Mit249,
D4Mit16, D4Mit204, and D4Mit71) markers. Percentages of both
B6 allele frequency and B6 homozygosity in the linked region
increased with the phenotype of enlargement of the ventricles
(from 60% (ventricle size, mean +5 SDs) to 70% (mean +8 SDs)),
while only a low percentage (30%) was detected in control mice.
Found at: doi:10.1371/journal.pone.0007868.s006 (0.52 MB TIF)
Table S1 3D-MRI analysis of wildtype C57BL/6J and C3H/
HeJ mice at the age of 3 months
Found at: doi:10.1371/journal.pone.0007868.s007 (0.26 MB TIF)
Table S2 Serum biochemical parameters and osmolarity of
control and mutant mice. Blood samples were collected from mice
at the age of 12 months (n=3 in each group) to produce serum
and analyzed for the levels of total-cholesterol (TCHO);
triglyceride (TG), glucose (GLU), magnesium (Mg), calcium (Ca),
creatinine (CRE), C-reactive protein (CRP), alanine aminotrans-
ferase (ALT), creatinine kinase (CPK), amylase (AMYL) and
osmolarity. Data are presented as the mean6SEM in each group.
Found at: doi:10.1371/journal.pone.0007868.s008 (0.25 MB TIF)
Table S3 A Chi-square test to assess the linkage of the B6 allele
at rs3091114 on chromosome 4 to hydrocephalus. The two-by-two
table demonstrates that the mutant B6 allele in this region was
significantly associated with the disease phenotype with
x
2=16.141, p,0.001.
Found at: doi:10.1371/journal.pone.0007868.s009 (0.23 MB
TIF)
Table S4 Morphological characteristics of Iba1-positive microg-
lia. Iba1-positive microglia were classified according to their
morphological features: (A) Ramified microglia (resting); (B) rod-
like/amoeboid microglia (activated); (C) elongated/bipolar mi-
croglia (chronically activated). Representative images of the
schematic illustrations (1), immunohistochemistry images (2), and
3D reconstructed images of immunofluorescence staining (3) are
presented.
Found at: doi:10.1371/journal.pone.0007868.s010 (1.09 MB TIF)
Table S5 Primers used for gene mapping on chromosome 4
Found at: doi:10.1371/journal.pone.0007868.s011 (0.69 MB TIF)
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